Potassium dihydrogen phosphate
Common Name: | Potassium dihydrogen phosphate |
IUPAC Name: | potassium;dihydrogen phosphate |
Molecular Formula: | KH2PO4 |
SMILES: | OP(=O)(O)[O-].[K+] |
Inchi: | 1S/K.H3O4P/c;1-5(2,3)4/h;(H3,1,2,3,4)/q+1;/p-1 |
Inchi Key: | GNSKLFRGEWLPPA-UHFFFAOYSA-M |
Cas No: | 7778-77-0 |
Name | Value |
Lipinski Violations | 0 |
Ghose Violations | 4 |
Veber Violations | 0 |
Egan Violations | 0 |
Muegge Violations | 2 |
---|
Name | Value |
Molecular Weight (g/mol) | 82.03 |
Mass (g/mol) | 135.933 |
Molar Refractivity | 11.56 |
Net Charge | |
HBD | |
HBA | 2 |
Rt Bonds | 0 |
Rings | |
TPSA | 40.13 |
Hetero Atoms | |
Heavy Atoms | 5 |
Aromatic Heavy Atoms | 0 |
Melting Point (°C) | 253 |
Boiling Point (°C@760.00mm Hg) | |
Vapor Pressure (mmHg@25.00 °C) | |
Vapor Density (Air =1) | |
Fraction Csp3 | 0.50 |
LogP | |
iLOGP | -5.74 |
XLOGP3 | -0.21 |
WLOGP | -1.24 |
MLOGP | -0.49 |
ESOL Log S | -0.22 |
ESOL Solubility (mg/ml) | 49.9 |
ESOL Solubility (mol/l) | 0.608 |
ESOL Class: esol_class | Very soluble |
Ali Log S | -0.18 |
Ali Solubility (mg/ml) | 54.7 |
Ali Solubility (mol/l) | 0.67 |
Ali Class | Very soluble |
Silicos-IT LogSw | 0.53 |
Silicos-IT Solubility (mg/ml) | 281 |
Silicos-IT Solubility (mol/l) | 3.42 |
Silicos-IT Class | Soluble |
---|
Name | Value |
GI Absorption | Low |
BBB Permeable | 0 |
PgP Substrate | 1 |
Log Kp (cm/s) | -6.95 |
Bioavailability Score | 0.55 |
Caco2 | 0 |
Human Intestinal Absorption | 1 |
Plasm Protein Binding | 0.988 |
CYP1A2 Inhibitor | 0 |
CYP2C19 Inhibitor | 0 |
CYP2C9 Inhibitor | 0 |
CYP2D6 inhibitor | 0 |
CYP3A4 inhibitor | 0 |
Ames mutagenesis | 0 |
Acute Oral Toxicity | 2.877 |
Carcinogenicity (Binary) | 0 |
Carcinogenicity (Trinary) | Non-required |
Eye Irritation | 1 |
Hepatotoxicity | 0 |
Androgen Receptor Binding | 0 |
Aromatase Binding | 0 |
Estrogen Receptor Binding | 0 |
Glucocorticoid Receptor Binding | 0 |
Thyroid Receptor Binding | 0 |
BRCP inhibitor | 0 |
BSEP inhibitor | 0 |
OATP1B1 inhibitor | 1 |
OATP1B3 inhibitor | 1 |
OATP2B1 inhibitor | 0 |
OCT1 inhibitor | 0 |
OCT2 inhibitor | 0 |
---|